Mice lacking the matrix metalloproteinase-9 gene reduce renal interstitial fibrosis in obstructive nephropathy

scientific article published on September 15, 2010

Mice lacking the matrix metalloproteinase-9 gene reduce renal interstitial fibrosis in obstructive nephropathy is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1152/AJPRENAL.00216.2010
P953full work available at URLhttp://intl-ajprenal.physiology.org/cgi/content/abstract/299/5/F973
https://www.physiology.org/doi/pdf/10.1152/ajprenal.00216.2010
P698PubMed publication ID20844022
P5875ResearchGate publication ID46281401

P2093author name stringLi Fang
Lei Jiang
Yang Zhou
Junwei Yang
Xiaohua Wang
Ping Wen
Weichun He
Ruoyun Tan
Mingxia Xiong
P2860cites workMesenchymal-epithelial transition in epithelial response to injury: the role of Foxc2Q24645523
Stage-specific action of matrix metalloproteinases influences progressive hereditary kidney diseaseQ25256594
Bone morphogenic protein-7 inhibits progression of chronic renal fibrosis associated with two genetic mouse modelsQ28201247
Matrix metalloproteinases and the regulation of tissue remodellingQ29618747
Role of cell surface metalloprotease MT1-MMP in epithelial cell migration over laminin-5.Q33843796
tPA protects renal interstitial fibroblasts and myofibroblasts from apoptosisQ34736911
Strategies for MMP inhibition in cancer: innovations for the post-trial era.Q34810420
TGF-beta signaling in renal diseaseQ34869314
Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic interventionQ35615604
Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosisQ35746891
Renal fibrosis: collagen composition and assembly regulates epithelial-mesenchymal transdifferentiationQ35746896
Renal fibrosis. Extracellular matrix microenvironment regulates migratory behavior of activated tubular epithelial cellsQ35747935
New insights into epithelial-mesenchymal transition in kidney fibrosisQ36010095
Progression in chronic kidney disease.Q36273914
Proteolytic exposure of a cryptic site within collagen type IV is required for angiogenesis and tumor growth in vivoQ36376907
Role of matrix metalloproteinases in renal pathophysiologiesQ36693229
Heme oxygenase-1 deficiency promotes epithelial-mesenchymal transition and renal fibrosisQ36842403
Extracellular matrix dynamics in development and regenerative medicineQ37063863
Matrix metalloproteinases: their potential role in the pathogenesis of diabetic nephropathyQ37069135
Matrix metalloproteinases stimulate epithelial-mesenchymal transition during tumor developmentQ37089026
Novel actions of tissue-type plasminogen activator in chronic kidney diseaseQ37115034
The role of the extracellular matrix in tissue distribution of macromolecules in normal and pathological tissues: potential therapeutic consequencesQ37157457
Matrix metalloproteinases and matrix receptors in progression and reversal of kidney disease: therapeutic perspectivesQ37225320
EMT and proteinuria as progression factorsQ37248336
Disruption of E-cadherin by matrix metalloproteinase directly mediates epithelial-mesenchymal transition downstream of transforming growth factor-beta1 in renal tubular epithelial cells.Q37278443
Disruption of tissue-type plasminogen activator gene in mice reduces renal interstitial fibrosis in obstructive nephropathyQ38494989
Expression and activation of pro-MMP-2 and pro-MMP-9 during rat liver regenerationQ38500247
Origin of renal myofibroblasts in the model of unilateral ureter obstruction in the rat.Q38846753
Glycogen synthase kinase 3beta is a novel regulator of high glucose- and high insulin-induced extracellular matrix protein synthesis in renal proximal tubular epithelial cellsQ39950939
Relaxin-1-deficient mice develop an age-related progression of renal fibrosisQ44900404
Matrix metalloproteinase 2 and basement membrane integrity: a unifying mechanism for progressive renal injuryQ46073081
Migration-stimulating factor displays HEXXH-dependent catalytic activity important for promoting tumor cell migrationQ46413198
Downregulation of SnoN expression in obstructive nephropathy is mediated by an enhanced ubiquitin-dependent degradation.Q54582707
Plasmin(ogen) Promotes Renal Interstitial Fibrosis by Promoting Epithelial-to-Mesenchymal Transition: Role of Plasmin-Activated SignalsQ57741352
PAI-1 deficiency attenuates the fibrogenic response to ureteral obstructionQ57741393
P433issue5
P407language of work or nameEnglishQ1860
P304page(s)F973-82
P577publication date2010-09-15
P1433published inAmerican Journal of Physiology - Renal PhysiologyQ2610177
P1476titleMice lacking the matrix metalloproteinase-9 gene reduce renal interstitial fibrosis in obstructive nephropathy
P478volume299

Reverse relations

cites work (P2860)
Q34796034A glimpse of matrix metalloproteinases in diabetic nephropathy
Q46112417Activation of Wnt5a-Ror2 signaling associated with epithelial-to-mesenchymal transition of tubular epithelial cells during renal fibrosis
Q37737827Alpha-lipoic acid ameliorates the epithelial mesenchymal transition induced by unilateral ureteral obstruction in mice
Q26827393Always cleave up your mess: targeting collagen degradation to treat tissue fibrosis
Q49106201Anti-MMP-9 Antibody: A Promising Therapeutic Strategy for Treatment of Inflammatory Bowel Disease Complications with Fibrosis
Q38077291Association of matrix metalloproteinase-9 level with the risk of renal involvement for Henoch-Schönlein purpura in children
Q35903772Cellular and molecular mechanisms of renal fibrosis
Q58799997Contribution of STAT3 to Inflammatory and Fibrotic Diseases and Prospects for its Targeting for Treatment
Q38568865Differential effects of Smad3 targeting in a murine model of chronic kidney disease
Q26825368Diverse functions of matrix metalloproteinases during fibrosis
Q90460068Doxycycline attenuates cisplatin-induced acute kidney injury through pleiotropic effects
Q40219212EMMPRIN expression is involved in the development of interstitial fibrosis and tubular atrophy in human kidney allografts
Q89619988ErHuang Formula Improves Renal Fibrosis in Diabetic Nephropathy Rats by Inhibiting CXCL6/JAK/STAT3 Signaling Pathway
Q38827683Erythropoietin protects the tubular basement membrane by promoting the bone marrow to release extracellular vesicles containing tPA-targeting miR-144.
Q37991204Fetal genitourinary imaging
Q92258757HHV-6A Infection and Systemic Sclerosis: Clues of a Possible Association
Q34461016Increased expression of intranuclear matrix metalloproteinase 9 in atrophic renal tubules is associated with renal fibrosis
Q35422209Investigating mechanisms of chronic kidney disease in mouse models
Q28535453Involvement of endoplasmic reticulum stress in albuminuria induced inflammasome activation in renal proximal tubular cells
Q84187904Involvement of matrix metalloproteinase-2 in the development of renal interstitial fibrosis in mouse obstructive nephropathy
Q34835060LRP-1: functions, signaling and implications in kidney and other diseases
Q46115768Leukocyte-derived MMP9 is crucial for the recruitment of proinflammatory macrophages in experimental glomerulonephritis
Q35553996Loss of matrix metalloproteinase-8 is associated with worsened recovery after ischemic kidney injury
Q35086941MMP-9 gene deletion mitigates microvascular loss in a model of ischemic acute kidney injury.
Q35715763Mannose receptor 2 attenuates renal fibrosis
Q35870277Matrix Metalloproteinase-2 Knockout and Heterozygote Mice Are Protected from Hydronephrosis and Kidney Fibrosis after Unilateral Ureteral Obstruction
Q51511058Matrix Metalloproteinase-7 Is a Urinary Biomarker and Pathogenic Mediator of Kidney Fibrosis.
Q89660177Matrix Metalloproteinases in Diabetic Kidney Disease
Q26741827Matrix Metalloproteinases in Non-Neoplastic Disorders
Q33667480Matrix metalloproteinase 9-dependent Notch signaling contributes to kidney fibrosis through peritubular endothelial-mesenchymal transition
Q46068772Matrix metalloproteinase-10 plays an active role in microvascular complications in type 1 diabetic patients
Q35715788Matrix metalloproteinase-7 as a surrogate marker predicts renal Wnt/β-catenin activity in CKD.
Q46046763Matrix metalloproteinase-9 deficiency attenuates diabetic nephropathy by modulation of podocyte functions and dedifferentiation
Q51835071Matrix metalloproteinase-9 of tubular and macrophage origin contributes to the pathogenesis of renal fibrosis via macrophage recruitment through osteopontin cleavage.
Q38164338Matrix metalloproteinases contribute to kidney fibrosis in chronic kidney diseases
Q27004621Matrix metalloproteinases in kidney homeostasis and diseases
Q64935938Matrix metalloproteinases in ureteropelvic junction obstruction.
Q33828362Membrane-type 4 matrix metalloproteinase (MT4-MMP) modulates water homeostasis in mice
Q61818598Mesenchymal Stem Cells in Renal Fibrosis: The Flame of Cytotherapy
Q49177880Mesenchymal stem cells protect against obstruction-induced renal fibrosis by decreasing STAT3 activation and STAT3-dependent MMP-9 production
Q35967489Renal interstitial fibrosis: mechanisms and evaluation
Q52687459Resolution of organ fibrosis.
Q37856705Scar wars: mapping the fate of epithelial-mesenchymal-myofibroblast transition
Q38776219Stimulation of transforming growth factor-beta-1 and contact with type I collagen cooperatively facilitate irreversible transdifferentiation in proximal tubular cells
Q89723568Targeting the progression of chronic kidney disease
Q38320337The inhibitory effect of chimeric decoy oligodeoxynucleotide against NF-κB and Sp1 in renal interstitial fibrosis
Q47909954The protective effects of bone morphogenetic protein-7 against epithelial injury and matrix metalloproteases upregulation induced by silica in vitro
Q38837268Use of Xenopus Frogs to Study Renal Development/Repair

Search more.